MapLight Therapeutics MPLT
NASDAQ MPLT
$8.25 +0.09 (+1.10%)
At close: Oct 22, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) EBIT (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) reported EBIT of -$63.55 million for Q2 2026, compared with -$30.66 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) EBIT (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MapLight Therapeutics' EBIT came in at -$209.09 million; for FY2025, it was -$169.08 million.

  • By year, EBIT came in at -$82.95 million in FY2024.
  • Five-year quarterly EBIT spans a low of -$83.38 million in Q4 2025 and a high of -$20.89 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 6.18 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.43 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 3.16 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.39 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.27 Bn
10 MapLight Therapeutics 373.45 Mn 373.45 Mn - -63.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -63.55 Mn
Dec 31, 2025 -83.38 Mn
Sep 30, 2025 -31.50 Mn
Jun 30, 2025 -30.66 Mn
Dec 31, 2024 -22.78 Mn
Sep 30, 2024 -20.89 Mn
API Access

MapLight Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=MPLT&period=max&api_key=YOUR_API_KEY